Fig. 5From: Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancerDistribution of BrCa patients based on the risk score. A-F Risk curve and scatter plot for the risk score and survival status of each BrCa group sample; G-I Heat map showing the expression profiles of Cuprotosis-related five lncrnas in all, train and test group samplesBack to article page